Charles Schwab’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-49,296
| Closed | -$1.07M | – | 3618 |
|
|
2022
Q4 | $1.07M | Buy |
49,296
+2,462
| +5% | +$53.2K | ﹤0.01% | 2755 |
|
|
2022
Q3 | $907K | Buy |
46,834
+515
| +1% | +$9.97K | ﹤0.01% | 2818 |
|
|
2022
Q2 | $920K | Buy |
46,319
+172
| +0.4% | +$3.42K | ﹤0.01% | 2829 |
|
|
2022
Q1 | $1.38M | Buy |
46,147
+375
| +0.8% | +$11.2K | ﹤0.01% | 2754 |
|
|
2021
Q4 | $1.07M | Buy |
45,772
+1,358
| +3% | +$31.7K | ﹤0.01% | 2883 |
|
|
2021
Q3 | $1.39M | Buy |
44,414
+1,910
| +4% | +$59.6K | ﹤0.01% | 2774 |
|
|
2021
Q2 | $1.5M | Sell |
42,504
-337
| -0.8% | -$11.9K | ﹤0.01% | 2803 |
|
|
2021
Q1 | $1.51M | Buy |
42,841
+782
| +2% | +$27.6K | ﹤0.01% | 2726 |
|
|
2020
Q4 | $1.58M | Buy |
42,059
+9,077
| +28% | +$341K | ﹤0.01% | 2660 |
|
|
2020
Q3 | $1.1M | Sell |
32,982
-1,347
| -4% | -$45K | ﹤0.01% | 2652 |
|
|
2020
Q2 | $910K | Buy |
34,329
+1,576
| +5% | +$41.8K | ﹤0.01% | 2651 |
|
|
2020
Q1 | $537K | Buy |
32,753
+4,221
| +15% | +$69.2K | ﹤0.01% | 2687 |
|
|
2019
Q4 | $726K | Buy |
28,532
+3,549
| +14% | +$90.3K | ﹤0.01% | 2697 |
|
|
2019
Q3 | $500K | Buy |
24,983
+1,407
| +6% | +$28.2K | ﹤0.01% | 2802 |
|
|
2019
Q2 | $761K | Buy |
23,576
+3,136
| +15% | +$101K | ﹤0.01% | 2666 |
|
|
2019
Q1 | $659K | Buy |
20,440
+1,341
| +7% | +$43.2K | ﹤0.01% | 2667 |
|
|
2018
Q4 | $469K | Hold |
19,099
| – | – | ﹤0.01% | 2794 |
|
|
2018
Q3 | $630K | Hold |
19,099
| – | – | ﹤0.01% | 2762 |
|
|
2018
Q2 | $679K | Buy |
+19,099
| New | +$679K | ﹤0.01% | 2696 |
|